Navigation Links
Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes
Date:7/21/2011

were taking sulfonylureas.  Those studies also showed that PTP-1B inhibition did not cause weight gain, another substantial advantage in the treatment of diabetic patients who are frequently obese and at high cardiovascular risk.  The data from these studies support the development of ISIS-PTP1BRx and should allow a very rapid route to clinical proof-of-concept.    

ISIS-PTP1BRx has the potential to be broadly useful in combination with most of the other commonly used drugs to treat patients with diabetes, including insulin, GLP-1 agonists, and more traditional drugs like metformin.  The initial clinical development plan for ISIS-PTP1BRx will focus on treating diabetic patients who are inadequately controlled on insulin, helping them utilize insulin more efficiently; and patients who are beginning to fail oral therapies, extending the time they have before becoming dependent on insulin.  

ABOUT ISIS-PTP1BRx

ISIS-PTP1BRx is an antisense drug that targets PTP-1B, a phosphatase that negatively regulates insulin receptor signaling and is responsible for turning off the activated insulin receptor.  Reducing PTP-1B enhances insulin activity. Scientists have long recognized PTP-1B as an attractive target to treat diabetes, but due to structural similarities among closely related proteins, pharmaceutical companies have had difficulty identifying small molecule drugs with sufficient specificity to be safe. ISIS-PTP1BRx selectively inhibits the production of PTP-1B without affecting other closely related proteins that, when inhibited, could lead to unwanted side effects. ISIS-PTP1BRx may offer new treatment to patients who do not respond adequately to currently available therapies such as glitazones, sulfonylureas, metformin, and GLP-1 based therapies, and has the potential to be used in combination with such other therapies.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... PARK, Calif. , Sept. 3, 2015 ... device company that is providing innovative evidence-based solutions for ... management will be presenting at the Morgan Stanley Global ... York City.  Nevro management is scheduled ... be accessible via a live audio webcast, accessible in ...
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis Pharma ... stage biotechnology company that applies its innovative ... needs, today announced plans to present at ... Fargo Healthcare Conference in BostonDate: , Thursday, ... Bank of America Merrill Lynch Global Healthcare ...
(Date:9/3/2015)...  As part of its ongoing commitment to provide ... R. Katz , MD, MPH, cardiac surgeon and chief ... Institute implanted the first HeartMate 3 left ventricular assist ... as part of the prestigious MOMENTUM 3™ Clinical Trial. ... the United States—and the first in central Virginia—chosen to ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, ... Day offer that cannot be passed up. FiltersFast.com, will ship all orders ... and water filtration product replacements. Take advantage of this promotion now through September ...
(Date:9/3/2015)... ... 2015 , ... Allied Anesthesia is proud to announce a continuing partnership with ... exception. , St. Jude was recently named one of the nation’s top stroke centers ... of only 10 hospitals in the state to earn the distinction. , The ...
(Date:9/3/2015)... NH (PRWEB) , ... September 03, 2015 , ... ... new agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide ... Epic EMR. , Through this agreement, Amerinet members will receive negotiated pricing on ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... for Increased Awareness of Disease, Funding for Research, SAN ... of 40,000 people in the U.S. who will lose,their lives ... will die from breast cancer. Yet, most people have never ... has no FDA approved treatment, no known cause and no ...
... BENSALEM, Pa., Oct. 31 Law Offices of Howard ... been filed on behalf,of purchasers of the common stock ... WCG ) between May 8, 2006 and October,24, 2007, ... in the United States District Court for the Middle ...
... Group Uses PETA Talking Points, Discourages Donations to,Legitimate ... health reporters,cover today,s report on global causes of ... nonprofit Center for Consumer Freedom is urging,them to ... animal,rights group calling itself "The Cancer Project." A ...
... Insurers Outline Features of their Countries, Models at,Event Sponsored ... Switzerland and The,Netherlands are among countries in Europe ... private sector plays a central role,in making care better ... countries have taken to cover all of their citizens, ...
... their risk of dying of the disease in half ... their cancer, compared to those who dont receive active ... diagnosed with localized prostate cancer, according to a study ... Therapeutic Radiology and Oncologys 49th Annual Meeting in Los ...
... says exercise and diet can lower chances of malignancies ... exercise and proper nutrition are key to reducing your ... adopt these practices, the better off you,ll be, a ... childbearing, breast-feeding, and adult height and weight also influence ...
Cached Medicine News:Health News:Goulet's Life Lost to Untreatable Lung Disease That Claims as Many Lives as Breast Cancer Each Year 2Health News:Consumer Alert: 'Cancer Project' Organization Is a Deceptive Animal Rights Group 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 3Health News:Radiation seed implant decreases risk of death over watchful waiting 2Health News:Obesity Linked to Increased Cancer Risk 2Health News:Obesity Linked to Increased Cancer Risk 3
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
... Quality EEG recording is assured even in ... has high performance, high sensitivity amplifiers, ... rejection filter, shielded electrodes and a high ... Neurofax is a complete and ready ...
... MagPro is the high performance magnetic stimulator ... in medical research. , ,MagPro is able to ... precise studies of the field/nerve interface can be ... biphasic waveform and coil-current direction. , , , ...
Medicine Products: